Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Excelsyn Engineering Technology was a UK-based engineering and technical services firm specializing in the pharmaceutical and biotechnology sectors. Operating as a subsidiary of Excelsyn Ltd, the company provided process engineering, project management, and facility design services, particularly for chemical development and manufacturing sites. Based in Newcastle-upon-Tyne, it supported the parent company's CDMO operations by designing and optimizing kilo labs, pilot plants, and large-scale manufacturing facilities. Following the acquisition of the Excelsyn group by Albany Molecular Research Inc. (AMRI) in 2010, the engineering unit was renamed and eventually dissolved in 2011. The parent company's operations were later integrated into AMRI, which rebranded as Curia in 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Excelsyn Engineering Technology.